{{Redirect|Tabe|the assessment tests called TABE|Tests of Adult Basic Education}}
{{Drugbox
| verifiedrevid = 464207822
| IUPAC_name = 11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6''H''-pyrido[2,3-''b''][1,4]benzodiazepin-6-one
| image = Pirenzepine.png
| width = 221
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|monograph|propantheline-bromide}}
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 28797-61-7
| ATC_prefix = A02
| ATC_suffix = BX03
| PubChem = 4848
| IUPHAR_ligand = 328
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00670
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4682
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3G0285N20N
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08389
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 8247
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 9967
<!--Chemical data-->
| C=19 | H=21 | N=5 | O=2
| molecular_weight = 351.403 g/mol
| smiles = O=C3c1ccccc1N(C(=O)CN2CCN(C)CC2)c4ncccc4N3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H21N5O2/c1-22-9-11-23(12-10-22)13-17(25)24-16-7-3-2-5-14(16)19(26)21-15-6-4-8-20-18(15)24/h2-8H,9-13H2,1H3,(H,21,26)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RMHMFHUVIITRHF-UHFFFAOYSA-N
}}

'''Pirenzepine''' ('''Gastrozepin'''), an [[Muscarinic acetylcholine receptor M1|M<sub>1</sub>]] selective antagonist, is used in the treatment of [[peptic ulcers]], as it reduces [[gastric acid]] secretion and reduces [[muscle spasm]]. It is in a class of drugs known as [[muscarinic receptor antagonists]] - [[acetylcholine]] being the neurotransmitter of the [[parasympathetic nervous system]] which initiates the rest-and-digest state (as opposed to fight-or-flight), resulting in an increase in gastric motility and digestion; whereas pirenzepine would inhibit these actions and cause decreased gastric motility leading to delayed gastric emptying and constipation.<ref name="Stolerman2010">{{cite book|last=Stolerman|first=Ian P.|title=Encyclopedia of Psychopharmacology|url=https://books.google.com/books?id=qoyYobgX0uwC&pg=PA811|accessdate=26 June 2013|date=2 August 2010|publisher=Springer|isbn=978-3-540-68698-9|page=811}}</ref> It has no effects on the brain and spinal cord as it cannot diffuse through the [[blood–brain barrier]].

Pirenzepine has been investigated for use in [[myopia]] control.<ref>{{cite journal | author = Czepita D | title = Fundamentals of modern treatment of myopia | journal = Ann Acad Med Stetin | volume = 51 | issue = 2 | pages = 5–9 | year = 2005 | pmid = 16519089}}</ref><ref>{{cite journal |vauthors=Walline JJ, Lindsley K, Vedula SS, Cotter SA, Mutti DO, Twelker JD |title= Interventions to slow progression of myopia in children |journal=Cochrane Database Syst Rev|issue=12 |pages=CD004916 |date=2011 |pmid= 22161388|doi= 10.1002/14651858.CD004916.pub3 |pmc=4270373}}</ref>

It promotes the homodimerization or [[GPCR oligomer|oligomerisation]] of [[Muscarinic acetylcholine receptor M1|M<sub>1</sub> receptors]].<ref>Pediani JD, Ward RJ, Godin AG, Marsango S, Milligan G (2016): "Dynamic Regulation of Quaternary Organization of the M1 Muscarinic Receptor by Subtype-Selective Antagonist Drugs." J Biol Chem. {{PMID|27080256}}</ref>

==See also==
* [[AFDX-384]]
* [[Telenzepine]]

== References ==
{{Reflist|2}}

{{Drugs for peptic ulcer and GORD}}
{{Muscarinic acetylcholine receptor modulators}}
{{Tricyclics}}

[[Category:Muscarinic antagonists]]
[[Category:Piperazines]]
[[Category:Lactams]]
[[Category:Pyridobenzodiazepines]]
[[Category:Acetamides]]
[[Category:Peripherally selective drugs]]


{{gastrointestinal-drug-stub}}